Nerve surgery and gene therapy: A neurobiological and clinical perspective

Journal of Hand Surgery: European Volume

Volumn 36, Issue 9, 2011, Pages 735-746

  Hoyng, S A ^a,b   Tannemaat, M R ^a,b   De Winter, F ^a,b   Verhaagen, J ^a,c   Malessy, M J A ^a,b  

^a NETHERLANDS INSTITUTE FOR NEUROSCIENCE   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Gene therapy; peripheral nerve; regeneration; viral vectors

Indexed keywords

NERVE GROWTH FACTOR;

ADENO ASSOCIATED VIRUS; ANIMAL; CYTOLOGY; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETIC TRANSDUCTION; GENETICS; HUMAN; INSTRUMENTATION; LENTIVIRINAE; METABOLISM; MICROSURGERY; NERVE CELL; NERVE REGENERATION; NEUROSURGERY; PERIPHERAL NERVE; PERIPHERAL NERVE INJURY; PHYSIOLOGY; REVIEW; SCHWANN CELL; TRANSGENE;

ANIMALS; DEPENDOVIRUS; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; LENTIVIRUS; MICROSURGERY; NERVE GROWTH FACTORS; NERVE REGENERATION; NEURONS; NEUROSURGICAL PROCEDURES; PERIPHERAL NERVE INJURIES; PERIPHERAL NERVES; SCHWANN CELLS; TRANSDUCTION, GENETIC; TRANSGENES;

EID: 80755168628     PISSN: 17531934     EISSN: 20436289     Source Type: Journal    
DOI: 10.1177/1753193411420348     Document Type: Review

References (101)

1. ALS CNTF Treatment Study Group. Neurology. 1996 ; 46: 1244-9
2. Aartsen WM, van Cleef KW, Pellissier LP, et al. GFAP-driven GFP expression in activated mouse Muller glial cells aligning retinal blood vessels following intravitreal injection of AAV2/6 vectors. PLoS One. 2010 ; 5: e12387 - e12387
3. Araki K, Shiotani A, Watabe K, et al. Adenoviral GDNF gene transfer enhances neurofunctional recovery after recurrent laryngeal nerve injury. Gene Ther. 2006 ; 13: 296-303 (Pubitemid 43223098)
4. Ayuso E, Mingozzi F, Bosch F. Production, purification and characterization of adeno-associated vectors. Curr Gene Ther. 2010 ; 10: 423-36
5. Battiston B, Papalia I, Tos P, Geuna S. Chapter 1: Peripheral nerve repair and regeneration research: A historical note. Int Rev Neurobiol. 2009 ; 87: 1-7
6. Baumgartner BJ, Shine HD. Neuroprotection of spinal motoneurons following targeted transduction with an adenoviral vector carrying the gene for glial cell line-derived neurotrophic factor. Exp Neurol. 1998 ; 153: 102-12 (Pubitemid 28452301)
7. Beard BC, Dickerson D, Beebe K, et al. Comparison of HIV-derived lentiviral and MLV-based gammaretroviral vector integration sites in primate repopulating cells. Mol Ther. 2007 ; 15: 1356-65 (Pubitemid 46969874)
8. Blankinship MJ, Gregorevic P, Allen JM, et al. Efficient transduction of skeletal muscle using vectors based on adeno-associated virus serotype 6. Mol Ther. 2004 ; 10: 671-8 (Pubitemid 39272856)
9. Blits B, Carlstedt TP, Ruitenberg MJ, et al. Rescue and sprouting of motoneurons following ventral root avulsion and reimplantation combined with intraspinal adeno-associated viral vector-mediated expression of glial cell line-derived neurotrophic factor or brain-derived neurotrophic factor. Exp Neurol. 2004 ; 189: 303-16 (Pubitemid 39221824)
10. Cao L, Lin EJ, Cahill MC, et al. Molecular therapy of obesity and diabetes by a physiological autoregulatory approach. Nat Med. 2009 ; 15: 447-54
11. Cartier N, Hacein-Bey-Abina S, Bartholomae CC, et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science. 2009 ; 326: 818-23
12. Chattopadhyay M, Wolfe D, Huang S, et al. In vivo gene therapy for pyridoxine-induced neuropathy by herpes simplex virus-mediated gene transfer of neurotrophin-3. Ann Neurol. 2002 ; 51: 19-27 (Pubitemid 34027973)
13. Cheng C, Zochodne DW. In vivo proliferation, migration and phenotypic changes of Schwann cells in the presence of myelinated fibers. Neuroscience. 2002 ; 115: 321-9 (Pubitemid 35232710)
14. Chenuaud P, Larcher T, Rabinowitz JE, et al. Optimal design of a single recombinant adeno-associated virus derived from serotypes 1 and 2 to achieve more tightly regulated transgene expression from nonhuman primate muscle. Mol Ther. 2004 ; 9: 410-18 (Pubitemid 38404530)
15. de Boer R, Knight AM, Spinner RJ, et al. In vitro and in vivo release of nerve growth factor from biodegradable poly-lactic-co-glycolic-acid microspheres. J Biomed Mater Res A. 2010 ; 95: 1067-73
16. de Ruiter GC, Spinner RJ, Malessy MJ, et al. Accuracy of motor axon regeneration across autograft, single-lumen, and multichannel poly(lactic-co-glycolic acid) nerve tubes. Neurosurgery. 2008 ; 63: 144-53
17. Dodd SL, Hain B, Senf SM, Judge AR. Hsp27 inhibits IKKbeta-induced NF-kappaB activity and skeletal muscle atrophy. FASEB J. 2009 ; 23: 3415-23
18. Eggers R, Hendriks WT, Tannemaat MR, et al. Neuroregenerative effects of lentiviral vector-mediated GDNF expression in reimplanted ventral roots. Mol Cell Neurosci. 2008 ; 39: 105-17
19. Eggers R, Tannemaat MR, Ehlert EM, Verhaagen J. A spatio-temporal analysis of motoneuron survival, axonal regeneration and neurotrophic factor expression after lumbar ventral root avulsion and implantation. Exp Neurol. 2010 ; 223: 207-20
20. Evans PJ, Bain JR, Mackinnon SE, Makino AP, Hunter DA. Selective reinnervation: A comparison of recovery following microsuture and conduit nerve repair. Brain Res. 1991 ; 559: 315-21
21. Favre D, Blouin V, Provost N, et al. Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus. J Virol. 2002 ; 76: 11605-11 (Pubitemid 35231316)
22. Fu SY, Gordon T. Contributing factors to poor functional recovery after delayed nerve repair: Prolonged axotomy. J Neurosci. 1995a ; 15: 3876-85
23. Fu SY, Gordon T. Contributing factors to poor functional recovery after delayed nerve repair: Prolonged denervation. J Neurosci. 1995b ; 15: 3886-95
24. Glorioso JC, Fink DJ. Herpes vector-mediated gene transfer in the treatment of chronic pain. Mol Ther. 2009 ; 17: 13-18
25. Goins WF, Lee KA, Cavalcoli JD, et al. Herpes simplex virus type 1 vector-mediated expression of nerve growth factor protects dorsal root ganglion neurons from peroxide toxicity. J Virol. 1999 ; 73: 519-32 (Pubitemid 28565397)
26. Gordon T, Sulaiman OA, Ladak A. Chapter 24: Electrical stimulation for improving nerve regeneration: Where do we stand?. Int Rev Neurobiol. 2009 ; 87: 433-44
27. Gossen M, Bujard H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc Natl Acad Sci USA. 1992 ; 89: 5547-51
28. Gossen M, Freundlieb S, Bender G, et al. Transcriptional activation by tetracyclines in mammalian cells. Science. 1995 ; 268: 1766-9
29. Gu HY, Chai H, Zhang JY, et al. Survival, regeneration and functional recovery of motoneurons after delayed reimplantation of avulsed spinal root in adult rat. Exp Neurol. 2005 ; 192: 89-99 (Pubitemid 40208541)
30. Haastert K, Grothe C. Gene therapy in peripheral nerve reconstruction approaches. Curr Gene Ther. 2007 ; 7: 221-8 (Pubitemid 46902204)
31. Haastert K, Lipokatic E, Fischer M, Timmer M, Grothe C. Differentially promoted peripheral nerve regeneration by grafted Schwann cells over-expressing different FGF-2 isoforms. Neurobiol Dis. 2006 ; 21: 138-53 (Pubitemid 41817314)
32. Hacein-Bey-Abina S, von KC, Schmidt M, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 2003 ; 302: 415-19 (Pubitemid 37296260)
33. Hargrove PW, Kepes S, Hanawa H, et al. Globin lentiviral vector insertions can perturb the expression of endogenous genes in beta-thalassemic hematopoietic cells. Mol Ther. 2008 ; 16: 525-33 (Pubitemid 351314992)
34. Hendriks WTJ, Eggers R, Carlstedt TP, et al. Lentiviral vector-mediated reporter gene expression in avulsed spinal ventral root is short-term, but is prolonged using an immune 'stealth' transgene. Restor Neurol Neurosci. 2007 ; 25: 585-99 (Pubitemid 351525720)
35. Hoke A, Brushart T. Introduction to special issue: Challenges and opportunities for regeneration in the peripheral nervous system. Exp Neurol. 2010 ; 223: 1-4
36. Hoke A, Gordon T, Zochodne DW, Sulaiman OAR. A decline in glial cell-line-derived neurotrophic factor expression is associated with impaired regeneration after long-term Schwann cell denervation. Exp Neurol. 2002 ; 173: 77-85 (Pubitemid 34081727)
37. Hoke A, Redett R, Hameed H, et al. Schwann cells express motor and sensory phenotypes that regulate axon regeneration. J Neurosci. 2006 ; 26: 9646-55 (Pubitemid 44427703)
38. Homs J, Ariza L, Pages G, et al. Schwann cell targeting via intrasciatic injection of AAV8 as gene therapy strategy for peripheral nerve regeneration. Gene Ther. 2011 ; 18: 622-30
39. Hu X, Cai J, Yang J, Smith GM. Sensory axon targeting is increased by NGF gene therapy within the lesioned adult femoral nerve. Exp Neurol. 2010 ; 223: 153-65
40. Ijkema-Paassen J, Meek MF, Gramsbergen A. Reinnervation of muscles after transection of the sciatic nerve in adult rats. Muscle Nerve. 2002 ; 25: 891-7 (Pubitemid 34578999)
41. Isaacs J. Treatment of acute peripheral nerve injuries: Current concepts. J Hand Surg Am. 2010 ; 35: 491-7
42. Jessen KR, Morgan L, Stewart HJ, Mirsky R. Three markers of adult non-myelin-forming Schwann cells, 217c(Ran-1), A5E3 and GFAP: Development and regulation by neuron-Schwann cell interactions. Development. 1990 ; 109: 91-103
43. Kaplitt MG, Feigin A, Tang C, et al. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: An open label, phase I trial. Lancet. 2007 ; 369: 2097-105 (Pubitemid 46935946)
44. Kaplitt MG, Leone P, Samulski RJ, et al. Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain. Nat Genet. 1994 ; 8: 148-54 (Pubitemid 24308362)
45. Kay MA, Glorioso JC, Naldini L. Viral vectors for gene therapy: The art of turning infectious agents into vehicles of therapeutics. Nat Med. 2001 ; 7: 33-40 (Pubitemid 32095639)
46. Kemp SW, Walsh SK, Zochodne DW, Midha R. A novel method for establishing daily in vivo concentration gradients of soluble nerve growth factor (NGF). J Neurosci Methods. 2007 ; 165: 83-8 (Pubitemid 47077503)
47. Koliatsos VE, Price WL, Pardo CA, Price DL. Ventral root avulsion: An experimental model of death of adult motor neurons. J Comp Neurol. 1994 ; 342: 35-44 (Pubitemid 24083342)
48. Kouyoumdjian JA. Peripheral nerve injuries: A retrospective survey of 456 cases. Muscle Nerve. 2006 ; 34: 785-8 (Pubitemid 44877565)
49. Kumar M, Keller B, Makalou N, Sutton RE. Systematic determination of the packaging limit of lentiviral vectors. Hum Gene Ther. 2001 ; 12: 1893-905 (Pubitemid 32947232)
50. Kutner RH, Zhang XY, Reiser J. Production, concentration and titration of pseudotyped HIV-1-based lentiviral vectors. Nat Protoc. 2009 ; 4: 495-505
51. Kwon I, Schaffer DV. Designer gene delivery vectors: Molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer. Pharm Res. 2008 ; 25: 489-99
52. Lambert PD, Anderson KD, Sleeman MW, et al. Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity. Proc Natl Acad Sci USA. 2001 ; 98: 4652-7 (Pubitemid 32295031)
53. Latta-Mahieu M, Rolland M, Caillet C, et al. Gene transfer of a chimeric trans-activator is immunogenic and results in short-lived transgene expression. Hum Gene Ther. 2002 ; 13: 1611-20 (Pubitemid 35034681)
54. Lavdas AA, Papastefanaki F, Thomaidou D, Matsas R. Cell adhesion molecules in gene and cell therapy approaches for nervous system repair. Curr Gene Ther. 2011 ; 11: 90-100
55. Lundberg C, Bjorklund T, Carlsson T, et al. Applications of lentiviral vectors for biology and gene therapy of neurological disorders. Curr Gene Ther. 2008 ; 8: 461-73
56. McDonald D, Cheng C, Chen Y, Zochodne D. Early events of peripheral nerve regeneration. Neuron Glia Biol. 2006 ; 2: 139-47
57. McPhail LT, Fernandes KJ, Chan CC, Vanderluit JL, Tetzlaff W. Axonal reinjury reveals the survival and re-expression of regeneration-associated genes in chronically axotomized adult mouse motoneurons. Exp Neurol. 2004 ; 188: 331-40 (Pubitemid 38891594)
58. Madison RD, Archibald SJ, Lacin R, Krarup C. Factors contributing to preferential motor reinnervation in the primate peripheral nervous system. J Neurosci. 1999 ; 19: 11007-16 (Pubitemid 30235744)
59. Maggi SP, Lowe JB, Mackinnon SE. Pathophysiology of nerve injury. Clin Plast Surg. 2003 ; 30: 109-26 (Pubitemid 36523139)
60. Malessy MJ, Pondaag W, van Dijk JG. Electromyography, nerve action potential, and compound motor action potentials in obstetric brachial plexus lesions: Validation in the absence of a 'gold standard'. Neurosurgery. 2009 ; 65 (4 Suppl). A153 - A159
61. Marks WJ, Ostrem JL, Verhagen L, et al. Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: An open-label, phase I trial. Lancet Neurol. 2008 ; 7: 400-8
62. Mason MR, Ehlert EM, Eggers R, et al. Comparison of AAV serotypes for gene delivery to dorsal root ganglion neurons. Mol Ther. 2010 ; 18: 715-24
63. Mason MR, Tannemaat MR, Malessy MJ, Verhaagen J. Gene therapy for the peripheral nervous system: A strategy to repair the injured nerve?. Curr Gene Ther. 2011 ; 11: 75-89
64. Midha R. Nerve transfers for severe brachial plexus injuries: A review. Neurosurg Focus. 2004 ; 16: E5 - E5
65. Millesi H, Ganglberger J, Berger A. Erfahrungen mit der Mikrochirurgie peripherer Nerven. Langenbeck's Archives of Surgery. 1966 ; 316: 723-723
66. Montini E, Cesana D, Schmidt M, et al. Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat Biotechnol. 2006 ; 24: 687-96 (Pubitemid 43882120)
67. Moradzadeh A, Borschel GH, Luciano JP, et al. The impact of motor and sensory nerve architecture on nerve regeneration. Exp Neurol. 2008 ; 212: 370-6
68. Nakajima H, Uchida K, Kobayashi S, et al. Rescue of rat anterior horn neurons after spinal cord injury by retrograde transfection of adenovirus vector carrying brain-derived neurotrophic factor gene. J Neurotrauma. 2007 ; 24: 703-12 (Pubitemid 46996029)
69. Naldini L, Blomer U, Gallay P, et al. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science. 1996 ; 272: 263-7 (Pubitemid 26119138)
70. Pan YA, Misgeld T, Lichtman JW, Sanes JR. Effects of neurotoxic and neuroprotective agents on peripheral nerve regeneration assayed by time-lapse imaging in vivo. J Neurosci. 2003 ; 23: 11479-88 (Pubitemid 37549705)
71. Pelleymounter MA, Cullen MJ, Wellman CL. Characteristics of BDNF-induced weight loss. Exp Neurol. 1995 ; 131: 229-38
72. Pereira Lopes FR, Lisboa BC, Frattini F, et al. Enhancement of sciatic-nerve regeneration after VEGF gene therapy. Neuropathol Appl Neurobiol. 2011 ;:
73. Raivich G, Bohatschek M, Da CC, et al. The AP-1 transcription factor c-Jun is required for efficient axonal regeneration. Neuron. 2004 ; 43: 57-67 (Pubitemid 38952819)
74. Rochkind S, Geuna S, Shainberg A. Chapter 25: Phototherapy in peripheral nerve injury: Effects on muscle preservation and nerve regeneration. Int Rev Neurobiol. 2009 ; 87: 445-64
75. Schmidt CE, Leach JB. Neural tissue engineering: strategies for repair and regeneration. Annu Rev Biomed Eng. 2003 ; 5: 293-347 (Pubitemid 40125315)
76. Scholz T, Krichevsky A, Sumarto A, et al. Peripheral nerve injuries: An international survey of current treatments and future perspectives. J Reconstr Microsurg. 2009 ; 25: 339-44
77. Senf SM, Dodd SL, McClung JM, Judge AR. Hsp70 overexpression inhibits NF-kappaB and Foxo3a transcriptional activities and prevents skeletal muscle atrophy. FASEB J. 2008 ; 22: 3836-45
78. Shu XQ, Mendell LM. Neurotrophins and hyperalgesia. Proc Natl Acad Sci USA. 1999 ; 96: 7693-6 (Pubitemid 29328342)
79. Snyder BR, Boulis NM, Federici T. Viral vector-mediated gene transfer for CNS disease. Expert Opin Biol Ther. 2010 ; 10: 381-94
80. Stieger K, Belbellaa B, Le Guiner C, Moullier P, Rolling F. In vivo gene regulation using tetracycline-regulatable systems. Adv Drug Deliv Rev. 2009 ; 61: 527-41
81. Sulaiman OA, Gordon T. Effects of short- and long-term Schwann cell denervation on peripheral nerve regeneration, myelination, and size. Glia. 2000 ; 32: 234-46
82. Nerve injuries and their repair: A critical appraisal. Melbourne: Churchill Livingstone ; 1991 :
83. Tannemaat MR, Boer GJ, Eggers R, Malessy MJ, Verhaagen J. From microsurgery to nanosurgery: How viral vectors may help repair the peripheral nerve. Prog Brain Res. 2009 ; 175: 173-86
84. Tannemaat MR, Boer GJ, Verhaagen J, Malessy MJ. Genetic modification of human sural nerve segments by a lentiviral vector encoding nerve growth factor. Neurosurgery. 2007 ; 61: 1286-94
85. Tannemaat MR, Eggers R, Hendriks WT, et al. Differential effects of lentiviral vector-mediated overexpression of nerve growth factor and glial cell line-derived neurotrophic factor on regenerating sensory and motor axons in the transected peripheral nerve. Eur J Neurosci. 2008a ; 28: 1467-79
86. Tannemaat MR, Verhaagen J, Malessy M. The application of viral vectors to enhance regeneration after peripheral nerve repair. Neurol Res. 2008b ; 30: 1039-46
87. Taylor CA, Braza D, Rice JB, Dillingham T. The incidence of peripheral nerve injury in extremity trauma. Am J Phys Med Rehabil. 2008 ; 87: 381-5 (Pubitemid 351571126)
88. Uchida N, Sutton RE, Friera AM, et al. HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells. Proc Natl Acad Sci USA. 1998 ; 95: 11939-44 (Pubitemid 28460518)
89. Viterbo F, Amr AH, Stipp EJ, Reis FJ. End-to-side neurorrhaphy: Past, present, and future. Plast Reconstr Surg. 2009 ; 124 (6 Suppl): e351 - e358
90. Waller A. Experiments on the section of the glossopharyngeal and hypoglossal nerves of the frog, and the observations of the alterations produced thereby in the structure of their primitive fibres. Phil Trans Roy Soc Lond B. 1850 ; 140: 423-9
91. Walsh S, Midha R. Practical considerations concerning the use of stem cells for peripheral nerve repair. Neurosurg Focus. 2009 ; 26: E2 - E2
92. Wang J, Zhang P, Wang Y, et al. The observation of phenotypic changes of Schwann cells after rat sciatic nerve injury. Artif Cells Blood Substit Immobil Biotechnol. 2010 ; 38: 24-8
93. Watabe K, Ohashi T, Sakamoto T, et al. Rescue of lesioned adult rat spinal motoneurons by adenoviral gene transfer of glial cell line-derived neurotrophic factor. J Neurosci Res. 2000 ; 60: 511-19 (Pubitemid 30252914)
94. Weber RA, Breidenbach WC, Brown RE, Jabaley ME, Mass DP. A randomized prospective study of polyglycolic acid conduits for digital nerve reconstruction in humans. Plast Reconstr Surg. 2000 ; 106: 1036-45
95. Xu QG, Midha R, Martinez JA, Guo GF, Zochodne DW. Facilitated sprouting in a peripheral nerve injury. Neuroscience. 2008 ; 152: 877-87
96. Yegiyants S, Dayicioglu D, Kardashian G, Panthaki ZJ. Traumatic peripheral nerve injury: A wartime review. J Craniofac Surg. 2010 ; 21: 998-1001
97. Young C, Miller E, Nicklous DM, Hoffman JR. Nerve growth factor and neurotrophin-3 affect functional recovery following peripheral nerve injury differently. Restor Neurol Neurosci. 2001 ; 18: 167-75 (Pubitemid 34258570)
98. Zacchigna S, Giacca M. Chapter 20: Gene therapy perspectives for nerve repair. Int Rev Neurobiol. 2009 ; 87: 381-92
99. Zaldumbide A, Weening S, Cramer SJ, et al. A potentially immunologically inert derivative of the reverse tetracycline-controlled transactivator. Biotechnol Lett. 2010 ; 32: 749-54
100. Zincarelli C, Soltys S, Rengo G, Rabinowitz JE. Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection. Mol Ther. 2008 ; 16: 1073-80 (Pubitemid 351737072)
101. Zuo Y, Lubischer JL, Kang H, et al. Fluorescent proteins expressed in mouse transgenic lines mark subsets of glia, neurons, macrophages, and dendritic cells for vital examination. J Neurosci. 2004 ; 24: 10999-1009 (Pubitemid 40012958)